RecruitingPhase 4ACTRN12605000024640
G-CSF for the prevention of mortality from severe melioidosis in Ubon Ratchathani, Thailand
Sponsor
Menzies School of Health Research, Charles Darwin University
Enrollment
88 participants
Start Date
Aug 1, 2003
Study Type
Interventional
Conditions
Summary
Recruitment ongoing at Sappasithiprasong Hospital, Ubon Ratchathani, Thailand
Eligibility
Sex: Both males and femalesMin Age: 14 Yearss
Inclusion Criteria1
- Severe sepsis (systemic inflammatory response syndrome and evidence of organ dysfunction) due to melioidosis suspected on clinical groups.
Exclusion Criteria1
- Children <14 years, pregnancy, hypersensitivity to study drugs, haematological malignancy, febrile neutropenia.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Study: Lenograstim 263mcg iv daily for 3 days
Study: Lenograstim 263mcg iv daily for 3 days
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12605000024640